Capturing the Natural Diversity of the Human Antibody Response against Vaccinia Virus

Vaccinia Virus A25 and A26 Proteins Are Fusion Suppressors for Mature Virions and Determine Strain-Specific Virus Entry Pathways into HeLa, CHO-K1, and L Cells

(2010) S.-J. Chang et al.   JOURNAL OF VIROLOGY

Smallpox vaccines induce antibodies to the immunomodulatory, secreted vaccinia virus complement control protein

(2009) J. E. Adamo et al.   JOURNAL OF GENERAL VIROLOGY

Considerations for the development of therapeutic monoclonal antibodies

(2008) Patrick G Swann et al.   CURRENT OPINION IN IMMUNOLOGY

Differential Antigen Requirements for Protection against Systemic and Intranasal Vaccinia Virus Challenges in Mice

(2008) D. R. Kaufman et al.   JOURNAL OF VIROLOGY

Redundancy and Plasticity of Neutralizing Antibody Responses Are Cornerstone Attributes of the Human Immune Response to the Smallpox Vaccine

(2008) M. R.-E.-I. Benhnia et al.   JOURNAL OF VIROLOGY

Vaccinia Virus A26 and A27 Proteins Form a Stable Complex Tethered to Mature Virions by Association with the A17 Transmembrane Protein

(2008) A. R. Howard et al.   JOURNAL OF VIROLOGY

Vaccinia Virus Extracellular Enveloped Virion Neutralization In Vitro and Protection In Vivo Depend on Complement

(2008) M. R.-E.-I. Benhnia et al.   JOURNAL OF VIROLOGY